-
Product Name
RPL38 antibody
- Documents
-
Description
RPL38 Rabbit Polyclonal antibody. Positive IHC detected in human pancreas cancer. Positive WB detected in HeLa cells, MCF7 cells. Observed molecular weight by Western-blot: 8kd
-
Tested applications
ELISA, WB, IHC
-
Species reactivity
human, mouse, rat; other species not tested.
-
Alternative names
RPL38 antibody; ribosomal protein L38 antibody; 60S ribosomal protein L38 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of RPL38 recombinant protein (Accession Number: NM_000999). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IHC: 1:20-1:200
-
Validations
HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:114894(RPL38 antibody) at dilution of 1:500
Immunohistochemical of paraffin-embedded human pancreas cancer using Catalog No:114894(RPL38 antibody) at dilution of 1:50 (under 10x lens)
Immunohistochemical of paraffin-embedded human pancreas cancer using Catalog No:114894(RPL38 antibody) at dilution of 1:50 (under 40x lens)
-
Background
RPL38 represents ribosomal protein L38
-
References
- Wu MY, Xie X, Xu ZK. PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradation of β-catenin. Oncology reports. 32(2):513-22. 2014.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"